Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coagulation factor analysis in patients on long-term anticoagulation.

H A Perkins, R L Biben

    California Medicine
    |March 1, 1970
    PubMed
    Summary

    For patients on warfarin therapy, additional clotting tests beyond the standard Quick prothrombin time offer no added benefit. A consistently performed Quick test using uniform thromboplastin is recommended for optimal monitoring.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Acute anemic events in sickle cell disease.

    Transfusion·2000
    Same author

    Heterosexual transmission of human immunodeficiency virus type 1 from transfusion recipients to their sex partners.

    Journal of acquired immune deficiency syndromes·1994
    Same author

    Declining efficacy of AIDS case list cross-referencing in human immunodeficiency virus look-back: 1981 through 1992.

    Transfusion·1994
    Same author

    The U.S. National Marrow Donor Program.

    The American journal of pediatric hematology/oncology·1994
    Same author

    Unrelated-donor marrow transplants: the experience of the National Marrow Donor Program.

    Clinical transplants·1994
    Same author

    Is white cell reduction cost-effective?

    Transfusion·1993

    Area of Science:

    • Clinical Pathology
    • Hematology
    • Pharmacology

    Background:

    • Warfarin is a widely used anticoagulant medication.
    • Monitoring warfarin therapy requires accurate assessment of blood clotting.
    • Various laboratory tests exist to evaluate coagulation status.

    Purpose of the Study:

    • To evaluate the utility of supplementary coagulation tests in patients on chronic warfarin therapy.
    • To determine if additional tests improve upon the information provided by the Quick prothrombin time.

    Main Methods:

    • A review of ninety studies involving 58 patients on chronic warfarin therapy.
    • Analysis included Quick prothrombin times, partial thromboplastin times, thromboplastin generation tests, and assays for clotting factors II, V, VII, VIII, IX, X, XI, and XII.

    Main Results:

    • No significant benefit was observed from supplementing the Quick prothrombin time with other coagulation tests.
    • The additional assays did not provide incremental clinical value for monitoring warfarin therapy.

    Conclusions:

    • The Quick prothrombin time, when performed uniformly with a standard thromboplastin reagent, is sufficient for monitoring warfarin therapy.
    • Standardization of the Quick test procedure is crucial for reliable and effective anticoagulant management.

    Related Experiment Videos